Institutional Risk Architecture

Geopolitical Trade Strength Index (GTSI)

A visual quantitative matrix assessing structural leverage, point-source dependencies, and strategic decoupling dynamics between the United States and China.

Master Index Summary

1. Defense & AI Technology USA +3.75
USA GTSI
68.75
CHINA GTSI
65.00
2. Healthcare Technology CHINA +10.00
USA GTSI
61.25
CHINA GTSI
71.25
3. Energy Security CHINA +27.50
USA GTSI
58.75
CHINA GTSI
86.25

1. Defense and AI Technology

1. Supply Chain Control & Self-Sufficiency
USA Score35/100
China Score70/100
  • US: High reliance on advanced logic foundry / packaging in Taiwan.
  • China: Total control of raw gallium, germanium, antimony inputs.
2. Innovation Leadership & IP
USA Score85/100
China Score65/100
  • US: Global monopoly on EDA software, algorithmic frameworks, frontier AI models.
  • China: Dominates computer vision patents, hardware robotics, drone manufacturing scale.
3. Regulatory & Trade Weaponization
USA Score80/100
China Score60/100
  • US: BIS aggressively wields Foreign Direct Product Rule (FDPR) compute freezes.
  • China: Implements targeted mineral export licenses and infrastructure bans.
4. Geopolitical Alliances & Market Share
USA Score75/100
China Score65/100
  • US: Assembles high-trust minilaterals (AUKUS, Chip 4 Alliance).
  • China: Locks in infrastructure and tech dominance across Global South via BRI.
Pillar Breakdowns USA Score China Score Net Advantage
1. Supply Chain Control & Self-Sufficiency 35 70 35 Points (China)
2. Innovation Leadership & IP 85 65 20 Points (USA)
3. Regulatory & Trade Weaponization 80 60 20 Points (USA)
4. Geopolitical Alliances & Global Market Share 75 65 10 Points (USA)
Composite Tech GTSI Score 68.75 65.00 USA +3.75
Tech Index Status Meter
80-100: Absolute Dominance
60-79: Moderate Advantage (USA)
40-59: Kinetic Stalemate
20-39: Transitionary Friction
0-19: Irrelevant
  • US commands software IP, but defense architecture remains captive to supply chains inside East Asia's strike zones.
  • China balances constraints via total command of hardware scaling and upstream mineral production.
Critical US Chokepoint
High concentration of sub-5nm logic foundry loops within the Taiwan Strait (TSMC).
Critical China Chokepoint
Dependency on Western EDA architectures and Dutch photolithography equipment (ASML).

2. Healthcare Technology

1. Supply Chain Control & Self-Sufficiency
USA Score25/100
China Score85/100
  • US: Reliant on external ecosystems for >70% of foundational chemical precursors/APIs.
  • China: Global dominant producer of APIs and basic generic antibiotics.
2. Innovation Leadership & IP
USA Score90/100
China Score55/100
  • US: Undisputed incubator for breakthrough biotech, mRNA platforms, and CRISPR patents.
  • China: Closes gaps in clinical trials and CAR-T lines; heavily weighted to generic biosimilars.
3. Regulatory & Trade Weaponization
USA Score65/100
China Score70/100
  • US: Wields the Biosecure Act to decouple Chinese CROs from financial loops.
  • China: Leverages domestic procurement volumes to suppress margins of foreign champions.
4. Geopolitical Alliances & Market Share
USA Score65/100
China Score75/100
  • US: Strict FDA standards secure premium high-value OECD consumption loops.
  • China: Dominates emerging systems via low-cost health infrastructure expansions.
Pillar Breakdowns USA Score China Score Net Advantage
1. Supply Chain Control & Self-Sufficiency 25 85 60 Points (China)
2. Innovation Leadership & IP 90 55 35 Points (USA)
3. Regulatory & Trade Weaponization 65 70 5 Points (China)
4. Geopolitical Alliances & Global Market Share 65 75 10 Points (China)
Composite Healthcare GTSI Score 61.25 71.25 China +10.00
Healthcare Index Status Meter
80-100: Absolute Dominance
60-79: Moderate Advantage (China)
40-59: Kinetic Stalemate
20-39: Transitionary Friction
0-19: Irrelevant
  • China's upstream chemical dominance forms an elite structural defense moat against short-term decoupling.
  • Advanced US biotechnology patents are logistically bottle-necked if foundational API inputs are disrupted.
Critical US Chokepoint
Systemic vulnerability on Chinese clusters for generic antibiotic bases and key inputs.
Critical China Chokepoint
Exposure to Western high-end diagnostic component software and clean biotech processing lines.

3. Energy Security

1. Supply Chain Control & Self-Sufficiency
USA Score40/100
China Score95/100
  • US: Dominant upstream fossil explorer (LNG/Crude) but deficient in processing capacity.
  • China: Absolute monopoly over clean transition processing (>80% solar/battery supply chains).
2. Innovation Leadership & IP
USA Score65/100
China Score85/100
  • US: Leads in advanced grid architectures and modular nuclear reactor (SMR) designs.
  • China: Industrial scale innovation in LFP/solid-state batteries and ultra-high-voltage transmission.
3. Regulatory & Trade Weaponization
USA Score75/100
China Score80/100
  • US: Enforces Inflation Reduction Act (IRA) rules and Sec 301 tariffs to exclude China tech.
  • China: Deploys state-directed pricing drops and rare earth licensing controls to undercut rivals.
4. Geopolitical Alliances & Market Share
USA Score55/100
China Score85/100
  • US: Deploys global LNG infrastructure exports to bridge European structural deficits.
  • China: Holds secure long-term offtake mineral mandates across Africa and Latin America.
Pillar Breakdowns USA Score China Score Net Advantage
1. Supply Chain Control & Self-Sufficiency 40 95 55 Points (China)
2. Innovation Leadership & IP 65 85 20 Points (China)
3. Regulatory & Trade Weaponization 75 80 5 Points (China)
4. Geopolitical Alliances & Global Market Share 55 85 30 Points (China)
Composite Energy GTSI Score 58.75 86.25 China +27.50
Energy Index Status Meter
80-100: Absolute Dominance (China)
60-79: Moderate Advantage
40-59: Kinetic Stalemate
20-39: Transitionary Friction
0-19: Irrelevant
  • China commands an entrenched structural monopoly over refined materials value loops.
  • US hydrocarbon self-sufficiency shields legacy assets but faces high exposure to future electrification trends.
Critical US Chokepoint
Complete domestic deficit in midstream commercial chemical refining of battery minerals.
Critical China Chokepoint
Extreme vulnerability to physical maritime interdictions along the Malacca Strait for crude requirements.

Final Synthesis & Master Summary Matrix

Strategic Sector USA Composite Score China Composite Score Net Advantage Battlefield Status
Defense and AI Technology 68.75 65.00 USA (+3.75) Moderate Advantage
Healthcare Technology 61.25 71.25 China (+10.00) Moderate Advantage
Energy Security 58.75 86.25 China (+27.50) Absolute Dominance
Late-2020s Predictive Forecast

China's structural position is strengthening at a faster trajectory due to its systemic near-monopoly over midstream critical mineral processing and scaled green manufacturing ecosystems, which cannot be quickly or cheaply replicated by Western capital expenditures. While the United States retains an elite tier advantage in advanced electronic design automation and foundational artificial intelligence architectures, this software dominance remains structurally constrained by acute physical vulnerabilities in baseline pharmaceutical inputs and manufacturing chains. Consequently, heading into the late 2020s, the balance of asymmetric economic leverage is tilting toward China's hardware-centric, material supply chain framework over the United States' software-and-IP heavy model.